| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.85B | +8.0% |
| Cost of Revenue | $1.35B | +7.6% |
| Gross Profit | $500.4M | +9.0% |
| R&D Expense | $49.5M | -7.3% |
| SG&A Expense | $211.7M | +14.3% |
| Operating Income | $221.3M | +6.3% |
| Pre-tax Income | $125.4M | -15.0% |
| Income Tax | $22.6M | -14.9% |
| Net Income | $102.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.2M | -63.1% |
| Accounts Receivable | $346.1M | +41.1% |
| Inventory | $253.7M | +2.7% |
| Current Assets | $770.1M | +14.7% |
| Total Assets | $3.41B | +10.8% |
| Current Liabilities | $232.0M | +2.1% |
| Long-term Debt | $1.19B | +19.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $196.1M | -4.4% |
| Capital Expenditures | $91.0M | -13.6% |
| Investing Cash Flow | -$270.7M | -38.5% |
| Financing Cash Flow | $43.6M | +227.0% |
| Free Cash Flow | $105.1M | +5.3% |
| -14.3% |
| EPS (Basic) | $2.96 | -17.1% |
| EPS (Diluted) | $2.89 | -14.0% |
| Total Liabilities |
| $1.66B |
| +14.1% |
| Stockholders' Equity | $1.75B | +7.9% |